|
100
|
285
|
5kadA |
Protein tyrosine phosphatase 1b n193a mutant in complex with tcs401, closed state |
|
94
|
279
|
5k9vA |
Protein tyrosine phosphatase 1b (1-301), open state |
|
106
|
295
|
5ka3A |
Protein tyrosine phosphatase 1b yaya (y152a, y153a) mutant in complex with tcs401, closed state |
|
108
|
298
|
5k9wA |
Protein tyrosine phosphatase 1b (1-301) in complex with tcs401, closed state |
|
96
|
279
|
5kacA |
Protein tyrosine phosphatase 1b p185g mutant, open state |
|
109
|
298
|
5ka7A |
Protein tyrosine phosphatase 1b t178a mutant in complex with tcs401, closed state |
|
43
|
157
|
5k25A |
Crystal structure of human phosphatase prl-2 in complex with the adp-bound bateman domain of human magnesium transporter cnnm3 |
|
100
|
284
|
5ka1A |
Protein tyrosine phosphatase 1b delta helix 7 mutant in complex with tcs401, closed state |
|
91
|
280
|
5ka4A |
Protein tyrosine phosphatase 1b t178a mutant, open state |
|
153
|
522
|
5ibmA |
Structure of s502p, a cancer-associated mutation of the oncogenic phosphatase shp2 |
|
158
|
523
|
5i6vA |
Structure of f285s, a cancer-associated mutation of the oncogenic phosphatase shp2 |
|
101
|
291
|
6h8sA |
Crystal structure of the mouse protein tyrosine phosphatase ptpn5 (step) in complex with compound bi-0314 |
|
103
|
288
|
6h8rA |
Crystal structure of the human protein tyrosine phosphatase ptpn5 (step) in complex with compound 2 |
|
97
|
282
|
6drbA |
Crystal structure of the yoph ptp1b wpd loop chimera 3 ptpase bound to tungstate |
|
108
|
282
|
6dr7A |
Yoph ptp1b wpd loop chimera 2 ptpase bound to vanadate |
|
100
|
282
|
6dr1A |
Yoph ptp1b chimera 2 ptpase |
|
107
|
281
|
6dr9A |
Crystal structure of the yoph ptp1b chimera 3 ptpase apo form |
|
104
|
282
|
6dt6A |
Crystal structure of the yoph ptp1b chimera 3 ptpase bound to vanadate |
|
158
|
523
|
6bmuA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitors shp099 and shp244 |
|
140
|
516
|
6bn5A |
Non-receptor protein tyrosine phosphatase shp2 f285s in complex with allosteric inhibitor jlr-2 |
|
157
|
523
|
6bmxA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitor shp844 |
|
153
|
523
|
6bmvA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitor shp504 |
|
159
|
523
|
6bmyA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitors shp099 and shp844 |
|
158
|
523
|
6bmrA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitor shp244 |
|
153
|
523
|
6bmwA |
Non-receptor protein tyrosine phosphatase shp2 in complex with allosteric inhibitors shp099 and shp504 |
|
99
|
286
|
6b8zA |
Multiconformer model of wt ptp1b with bb3 at 273 k |
|
103
|
298
|
6b8eA |
Multiconformer model of apo wt ptp1b with glycerol at 180 k |
|
97
|
285
|
6b95A |
Multiconformer model of k197c ptp1b tethered to compound 2 at 100 k |
|
94
|
282
|
6baiA |
Multiconformer model of apo k197c ptp1b at 100 k |
|
104
|
298
|
6b90A |
Multiconformer model of apo wt ptp1b with glycerol at 100 k (alternative refinement of pdb 1sug showing conformational heterogeneity) |
|
113
|
299
|
6b8tA |
Multiconformer model of apo wt ptp1b with glycerol at 240 k |
|
114
|
298
|
6b8xA |
Multiconformer model of apo wt ptp1b with glycerol at 278 k |
|
145
|
524
|
6atdA |
Oxidized shp2 forms a disulfide bond between cys367 and cys459 |
|
104
|
282
|
4zn5A |
Yoph w354y yersinia enterocolitica ptpase bond with divanadate glycerol ester in the active site |
|
104
|
282
|
4zi4A |
Yoph w354h yersinia enterocolitica ptpase bond with divanadate glycerol ester in the active site |
|
105
|
282
|
4z6bA |
Yoph w354h yersinia enterocolitica ptpase in the apo form |
|
154
|
526
|
4dgpA |
The wild-type src homology 2 (sh2)-domain containing protein tyrosine phosphatase-2 (shp2) |
|
162
|
525
|
4dgxA |
Leopard syndrome-associated shp2/y279c mutant |
|
188
|
575
|
4bpcA |
Structure of the catalytic domain of protein tyrosine phosphatase sigma in the sulfenic acid form |
|
99
|
298
|
4az1A |
Crystal structure of the trypanosoma cruzi protein tyrosine phosphatase tcptp1, a potential therapeutic target for chagas' disease |
|
100
|
287
|
4bjoA |
Nitrate in the active site of ptp1b is a putative mimetic of the transition state |
|
85
|
282
|
3zm2A |
Catalytic domain of human shp2 |
|
92
|
280
|
3zv2A |
Human protein-tyrosine phosphatase 1b c215a, s216a mutant |
|
89
|
280
|
3zmpA |
Src-derived peptide inhibitor complex of ptp1b |
|
65
|
273
|
3zmqA |
Src-derived mutant peptide inhibitor complex of ptp1b |
|
91
|
282
|
3zm1A |
Catalytic domain of human shp2 |
|
84
|
282
|
3zm3A |
Catalytic domain of human shp2 |
|
88
|
282
|
3zm0A |
Catalytic domain of human shp2 |
|
112
|
282
|
3u96A |
Crystal structure of yophq357f(catalytic domain, residues 163-468) in complex with pncs |
|
183
|
576
|
3sr9A |
Crystal structure of mouse ptpsigma |
